Nuformix (LON:NFX) Trading 20% Higher

Nuformix plc (LON:NFX)’s stock price was up 20% during mid-day trading on Tuesday . The company traded as high as GBX 0.22 ($0.00) and last traded at GBX 0.21 ($0.00). Approximately 6,297,677 shares changed hands during mid-day trading, an increase of 162% from the average daily volume of 2,399,620 shares. The stock had previously closed at GBX 0.18 ($0.00).

Nuformix Trading Up 25.7 %

The company has a current ratio of 1.51, a quick ratio of 3.35 and a debt-to-equity ratio of 1.17. The firm has a market capitalization of £1.80 million, a P/E ratio of -1.63 and a beta of 0.28. The business has a 50 day moving average of GBX 0.18 and a 200-day moving average of GBX 0.22.

Nuformix Company Profile

Nuformix plc operates in the field of pharmaceutical development for treating fibrosis and oncology through drug repurposing in the United Kingdom. It offers NXP001, which has completed Phase 1 for use in oncology supportive care. The company is also developing NXP004, a novel form of Olaparib, which is in the IP generation phase for treating oncology; and NXP002 that is in pre-clinical stage for the treatment of idiopathic pulmonary fibrosis.